Crucell Announces PER.C6 Licensing Agreement with Tibotec
23 nov. 2005 02h06 HE
|
Crucell N.V.
LEIDEN, Netherlands, Nov. 23, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has signed a PER.C6(r) license agreement with...
Actelion and UCB Enter Into Assignment and License Agreement for Zavesca(miglustat)
17 nov. 2005 01h19 HE
|
UCB
BRUSSELS, Belgium and ALLSCHWIL, Switzerland, Nov. 17, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) and UCB (Euronext:UCB) today announced that the two companies have replaced their existing license...
Kos and Jerini Sign Exclusive Collaboration and License Agreement for Development, Marketing and Distribution of Icatibant in The United States and Canada
07 nov. 2005 03h03 HE
|
Jerini AG
-- Kos to develop, market and distribute Icatibant in the U.S. and
Canada
-- Icatibant, in final Phase III clinical trials for hereditary
angioedema (HAE), represents next potential new...
Pop3 Media Corp. Announces New CEO
03 nov. 2005 10h33 HE
|
Pop3 Media Corp
BEVERLY HILLS, Calif., Nov. 3, 2005 (PRIMEZONE) -- Pop3 Media Corp.(OTCBB:POPTE) today announced the appointment of Ari Bass as its new CEO effective October 31, 2005.
"We are extremely pleased...
Crucell and DSM Announce PER.C6 Licensing Agreement with IQ Corporation for Production of Monoclonal Antibodies against Anthrax
19 oct. 2005 02h12 HE
|
Crucell N.V.
LEIDEN and SITTARD, Netherlands, Oct. 19, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and allied contract manufacturer DSM Biologics announced today...
World Leading Supplier of Entertainment and Communications Systems Invests $2.2M in Telelogic's ELM Solution
03 oct. 2005 03h21 HE
|
Telelogic
MALMO, Sweden and IRVINE, Calif., Oct. 3, 2005 (PRIMEZONE) -- Telelogic (Stockholm Exchange:TLOG), the leading provider of software solutions that align advanced systems and software development with...
MorphoSys Announces Cross Licensing of Technologies with Lilly: AME Patent Dispute Settled
23 sept. 2005 02h35 HE
|
MorphoSys AG
MARTINSRIED, Germany, Sept. 23, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) today announced a cross license agreement with Eli Lilly and Company on the use of...
Electric Aquagenics Unlimited, Inc. Announces Latin American License Agreement
20 sept. 2005 09h00 HE
|
EAU Technologies, Inc
LINDON, Utah, Sept. 20, 2005 (PRIMEZONE) -- Electric Aquagenics Unlimited, Inc. (EAU) (OTCBB:EAQU) today announced that it has licensed the exclusive rights to market its Empowered Water(tm) and...
WayPoint Biomedical Signs Letter of Intent and Enters Into Negotiations With Martin Schwanz and Associates to Exclusively Represent WayPoint's Drink Detective Product Range in Canada
16 sept. 2005 16h15 HE
|
WayPoint Biomedical, Inc.
HUNTINGTON BEACH, Calif., Sept. 16, 2005 (PRIMEZONE) -- WayPoint Biomedical Inc. (Pink Sheets:WYPB) has signed a Letter of Intent with Schwanz and Associates to enter into negotiations with WayPoint...
Biovitrum and Santhera Sign an Exclusive License and Collaboration Agreement for the Development of DPP-IV Inhibitors for the Treatment of Type 2 Diabetes and Other Metabolic Diseases
17 août 2005 02h10 HE
|
Biovitrum
STOCKHOLM, Sweden, Aug. 17, 2005 (PRIMEZONE) -- Biovitrum AB, Sweden, and Swiss-based Santhera Pharmaceuticals AG have signed a license and collaboration agreement that grants Biovitrum the exclusive...